Galapagos NV
GLPG
#4956
Rank
HK$14.59 B
Marketcap
HK$217.25
Share price
0.00%
Change (1 day)
-3.60%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): HK$4.29 Billion

According to Galapagos NV's latest financial reports the company's current earnings are HK$1.22 Billion. In 2025 the company made an earning of HK$2.88 Billion, an increase over its 2024 earnings that were of -HK$45.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$4.29 B49.08%
2025 HK$2.88 B-6464.81%
2024 -HK$45.28 Million-82.77%
2023 -HK$0.27 Billion-85.59%
2022 -HK$1.83 Billion60.71%
2021 -HK$1.14 Billion-60.08%
2020 -HK$2.85 Billion-331.44%
2019 HK$1.22 B-523.76%
2018 -HK$0.29 Billion-72.34%
2017 -HK$1.05 Billion-329.59%
2016 HK$0.45 B-144.3%
2015 -HK$1.04 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.52 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.74 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$51.68 B 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$59.99 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$103.03 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$114.88 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$78.43 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-HK$0.42 Billion-109.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$17.79 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel